DHNasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Definitive Healthcare Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$1.10+0.10 (+10.00%)
Close on Oct 19, 2026
- Market cap
- $116.39M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2018 to 2025
Gross margin
75.9%+1.6 pts over 5 years
Operating margin
-92.9%−79.4 pts over 5 years
Net margin
-57.5%−57.5 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -4.2% | +2.7% | +15.3% | – | |
| Gross profit | -7.2% | +0.6% | +15.8% | – | |
| Free cash flow | -19.2% | +10.8% | +11.2% | – |
Returns and balance sheet
8 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2018 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on assets | – | – | -15.2% | |
| Current ratio | – | 0.70 | 1.64 | |
| Net debt to EBITDA | – | -29.67× | -0.01× | |
| Interest coverage | – | -0.4× | -19.9× | |
| Capex to revenue | – | 1.2% | 6.9% | |
| Diluted shares | – | – | 107M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Definitive Healthcare generated $213.95M from operations and spent $350.69M on capital expenditure, dividends and share buybacks. 13% of that went back into the business.
Generated
$213.95M
Used
$350.69M
Capital expenditure$47.10M13%Dividends$00%Share buybacks$303.59M87%
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
5of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero-$138.93M
- Cash generatingOperating cash flow above zero$53.78M
- Return on assets improvedROA up on the prior year-22.6% → -12.8%
- Earnings backed by cashOperating cash flow above net income$53.78M vs -$138.93M
- Less leverageLong-term debt to assets fell21.1% → 21.2%
- Better liquidityCurrent ratio rose2.30 → 1.64
- No dilutionShare count did not rise117M → 107M
- Gross margin improvedGross margin up on the prior year78.30% → 75.88%
- More efficientAsset turnover rose0.14 → 0.22